Interconnected joints glowing with inner light, symbolizing rheumatoid arthritis, with a backdrop of Indonesian landscape.

Unlocking Arthritis Insights: Can a Simple Blood Test Predict Disease Severity?

Beau Callahan in Health & Wellness December 2025 • 4 min read.

"New Research Explores the Link Between COMP Levels, DAS28, and Rheumatoid Arthritis"

Rheumatoid arthritis (RA) is more than just achy joints; it's a chronic autoimmune disease where your body mistakenly attacks itself. This can lead to painful swelling in the joints, often affecting hands and feet symmetrically, and if left unchecked, it can cause lasting damage and reduce quality of life.

Early diagnosis and intervention are key to managing RA effectively. Doctors use various tools to assess how active the disease is, one of which is the Disease Activity Score 28 (DAS28). But could there be other indicators, perhaps found in a simple blood test, that offer a more complete picture?

Researchers in Bandung, Indonesia, investigated the potential link between DAS28 scores and the levels of cartilage oligomeric matrix protein (COMP) in the blood of RA patients. COMP is a protein involved in cartilage structure, and some believe it could serve as a biomarker for joint damage.

Decoding the DAS28 Score: What Does It Really Tell Us?

Interconnected joints glowing with inner light, symbolizing rheumatoid arthritis, with a backdrop of Indonesian landscape.

The Disease Activity Score 28 (DAS28) is a widely used measure to evaluate the severity of rheumatoid arthritis. It considers several factors, including the number of tender and swollen joints (out of a total of 28 specific joints), the patient's overall assessment of their health, and levels of erythrocyte sedimentation rate (ESR), an indicator of inflammation.

While DAS28 provides a valuable snapshot of disease activity, it has limitations. The ESR component, for example, is not specific to RA and can be influenced by other inflammatory conditions. This is where the search for additional biomarkers like COMP comes in.

DAS28: Combines joint counts, patient assessment, and ESR.
ESR: A general marker of inflammation, not specific to RA.
COMP: A protein potentially linked to cartilage damage.

The Indonesian study involved RA patients visiting a rheumatology clinic. Researchers measured their DAS28 scores and COMP levels in their blood. The goal was to determine if a correlation exists between these two measures. If COMP levels rise and fall in tandem with DAS28 scores, it could suggest that COMP is a reliable indicator of disease activity.

The Verdict: COMP Levels and DAS28 - Not Always in Sync

The study found no direct correlation between DAS28 scores and COMP levels in RA patients. This suggests that COMP levels, at least in this study, may not reliably reflect overall disease activity as measured by DAS28. The researchers pointed out that DAS28 includes ESR, which isn't specific to RA inflammation. Other inflammatory conditions could elevate ESR, thus affecting the DAS28 score without necessarily impacting COMP levels.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is rheumatoid arthritis (RA) and why is early diagnosis so important?

Rheumatoid arthritis (RA) is a chronic autoimmune disease where the body's immune system mistakenly attacks its own tissues, primarily affecting the joints. This leads to painful swelling, often in the hands and feet symmetrically. Early diagnosis and intervention are crucial because RA can cause lasting joint damage and significantly reduce the quality of life. Identifying RA early allows for timely treatment, which can help manage symptoms, slow disease progression, and prevent severe complications.

What factors are included in the DAS28 score, and how is it used to assess the severity of rheumatoid arthritis?

The Disease Activity Score 28 (DAS28) is a widely used tool to evaluate the severity of rheumatoid arthritis. It combines several factors to provide a comprehensive assessment. These factors include the number of tender and swollen joints out of a total of 28 specific joints, the patient's overall assessment of their health, and levels of erythrocyte sedimentation rate (ESR), an indicator of inflammation. The DAS28 score helps doctors understand the disease's activity level, guiding treatment decisions and monitoring the effectiveness of interventions.

What is COMP, and why is it being investigated as a potential biomarker for rheumatoid arthritis?

COMP, or cartilage oligomeric matrix protein, is a protein involved in the structure of cartilage. Researchers are investigating COMP as a potential biomarker for rheumatoid arthritis because it is associated with joint damage. The idea is that increased levels of COMP in the blood might indicate cartilage breakdown, reflecting the severity of RA and the extent of joint damage. This research aims to find additional indicators, potentially through a simple blood test, that offer a more complete picture of disease activity, supplementing existing measures like the DAS28 score.

Did the study find a direct correlation between COMP levels and DAS28 scores? If not, what are the implications of this finding?

The study conducted in Bandung, Indonesia, did not find a direct correlation between DAS28 scores and COMP levels in RA patients. This suggests that COMP levels may not reliably reflect overall disease activity as measured by the DAS28. The researchers pointed out that DAS28 includes ESR, which isn't specific to RA inflammation. Other inflammatory conditions could elevate ESR, thus affecting the DAS28 score without necessarily impacting COMP levels. This implies that COMP might not be a standalone indicator of RA severity, or that its value as a biomarker may be limited by the influence of factors other than RA-specific inflammation.

What are the limitations of using DAS28 to assess rheumatoid arthritis severity, and how could additional biomarkers like COMP improve the diagnostic process?

While the DAS28 score is valuable for assessing rheumatoid arthritis, it has limitations. One key component, the erythrocyte sedimentation rate (ESR), is a general marker of inflammation and is not specific to RA. This means that the DAS28 score can be influenced by other inflammatory conditions, potentially leading to an inaccurate assessment of RA activity. Additional biomarkers, like COMP, were hoped to offer a more specific measure of RA-related joint damage. Although this study did not find a direct correlation, future research into other biomarkers could improve the diagnostic process by providing a more complete and accurate picture of the disease state, independent of general inflammation markers, ultimately enabling more tailored and effective treatment strategies.